Monsanto Seeks To Overturn $80M Roundup Lawsuit Verdict

Only a few weeks after a California state court jury found that Monsanto should pay more than $2 billion in compensation to a couple diagnosed with non-Hodgkins lymphoma following exposure to Roundup, the company is asking that a prior verdict of $80 million returned by a separate jury in the federal court system be overturned, arguing that there was insufficient evidence to justify the award.

Bayer and it’s Monsanto unit face an estimated 15,000 Roundup lawsuits pending nationwide, each raising similar allegations that the manufacturer failed to warn consumers that long-term exposure to the weedkiller increases the risk of cancer.

On May 30, a motion (PDF) was filed in the U.S. District Court for the Northern District of California, asking for judgment as a matter of law, or a new trial, involving claims brought by Edwin Hardeman, who was awarded $5 million in compensatory damages and $75 million in punitive damages by a federal jury in March.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

Hardeman established at trial that Roundup was a substantial factor in his caner diagnosis, which came after years of spraying Roundup to kill weeds around his home.

The verdict was the second of three massive jury awards returned by different juries against Monsanto in less than a year, was viewed as a “bellwether” case in the federal court system, which was designed to help parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation.

Given common questions of fact and law, the federal litigation is currently centralized before U.S. District Judge Vince Chhabria in the U.S. District Court for the Northern District of California, as part of a multidistrict litigation (MDL).

Although Judge Chhabria previously denied motions filed by Monsanto to dismiss the case, finding that plaintiffs expert witness testimony was sufficiently reliable for a jury to consider the case, Monsanto is now asking the same Court to overturn the verdict, or grant a new trial.

The motion marks the beginning of the appeal process for Monsanto, who was required to file a supersedeas bond (PDF) for more than $100 million, to cover amount of the judgment and interest that may accrue during the appeal efforts.

While each of the first three verdicts are being appealed, Monsanto is expected to face additional trials in the state and federal court systems.

Judge Chhabria has scheduled the next federal bellwether trial to begin on February 10, 2020, involving a lawsuit filed by a woman diagnosed with non-Hodgkins lymphoma following extensive use of Roundup in her herb garden for years.

If Monsanto fails to negotiate Roundup settlements or otherwise resolve the litigation, it is expected that Judge Chhabria will begin remanding large numbers of individual cases for trial.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.